1. ADRENERGIC MEDICATIONS (sympathomimetic drugs) BY:DR.ISRAA OMAR

2. Adrenergic transmission (synthesis) NA is synthesized in the axon of the noradrenergic neurons. Tyrosine is taken up by these neurons and by the action of tyrosine hydroxylase it is converted to DOPA Then by the action of DOPA decarboxylase it is converted to DOPAMINE and then to noradrenaline by hydroxylase enzyme Then in the adrenal medulla NA will change in to adrenaline by the action of phenylethanolamine N-methyl transferase enzyme Isoprenaline is a synthetic derivative of NA

3. Storage and release The synthesized NA is stored,together with ATP and chromogranin, in the vesicles in the nerve terminal and chromaffin cells in the adrenal medulla It is released by two ways 1.By exocytosis ;influx of Ca to presynaptic neuron will lead to release of NE by exocytosis in to the synaptic cleft 2.Non- exocytosis release: certain drugs like amphetamine replace and release the NE from the vesicles

4. Continue Noradrenaline : release is mainly regulated by an auto inhibitory feed back mechanism (the released noradrenaline in the synapse will stimulate α2 receptors in the presynaptic neuron and in turn inhibit the release of NE.

5. Elimination of catecholamine Catecholamine(NA, adrenaline, isoprenaline) are eliminated by re- uptake and/or metabolic degradation, they are removed by one of the 3 mechanisms: 1.Uptake 1: it is uptake to pre synaptic neuron and it is more selective to NA,it can be inhibited by amphetamine and tricyclic antidepressant 2.Uptake 2: extraneuronal reuptake :it is uptake by effector organ like heart and smooth muscle,it is relatively selective to adrenaline 3.Some of them may escape in to the vascular system and degraded by hepatic enzymes

6. Continue…….. Catecolamine are metabolized by: 1.MAO monoamine oxidase enzyme of the mitochondria in the cells and this enzyme is particularly abundant in neurons 2.Catechol-O-methyl transferase (COMT) found in variety of neuronal and non- neuronal tissues.

7. Classification of adrenoceptors They are divided in to 2 classes 1.α receptor (α1 andα2) 2.βReceptors (β1,β2andβ3) Αlpha: – α 1: activate phospholipase C, thus producing IP3 and DAG as a second messengers; – α2: inhibit adenylate cyclase, and thus decrease cAMP formation. Beta: – Beta receptors 1,2 and 3 stimulate adenylate cyclase and therefore increase cAMP formation

8. Action of adrenergic receptors α1: – Found in the smooth muscle of many organs and they cause contraction of the blood vessels, relaxation of the GIT and glycogenlysis α2: – Found in presynaptic neuron,CNS, blood vessels, it inhibit transmitter release, in addition they cause platelets aggregation and blood vessel contraction

9. β1: – Mainly in the heart, stimulation result in an increase cardiac out put and heart rate β2: – Present in the smooth muscle of many organs and its stimulation lead to bronchodilation, peripheral vasodilation, relaxation of the visceral smooth muscle and skeletal muscle tremor Β3: – Present in fat cells and cause lipolysis Action of adrenergic receptors

10. Adrenaline, noradrenaline and isoprenaline act on both α and β receptors but with different potency α receptors stimulated more by noradrenaline and less with isoprenaline, β stimulated more with isoprenaline and less with NE.

11. Sympathomimetics drugs A.Direct acting : 1.Alpha agonists 2.Beta agonists B.Indirect acting 1.Releasers 2.Reuptake inhibitors The direct acting drugs can also be divided in to catecholamine and non-catecholamine

12. A. Direct acting catecholamines 1.Epinephrine: – α (all types) and β (all types) agonist used to treat anaphylaxis and with local anesthesia 2.Norepinpherine: – α (all types) and only β1 agonist used to treat neurogenic shock, last resort therapy in shock patient

13. Continue 3.Dopamine: – Stimulate D1, β1 and α1,receptors – It is used to treat shock and acute renal failure due to insufficient blood flow to the kidney, it is superior to the NE in management of shock why? 4.Dobutamine: – β 1 agonist used to increase cardiac out-put in patient with heart failure with little change in heart rate and no effect in blood vessels

14. α1 adrenoceptors agonist (noncatecholamines) 1.Phenylephrine : – Used topically on nasal mucous membrane as nasal decongestant and on the eye to cause mydriasis and for treatment of open angle glaucoma because it cause reduce the secretion of aqueous humor – It doesn’t affect the heart directly but can cause reflex bradycardia as a result of vasoconstriction 2.Methoxamine: – Used to overcome hypotension during surgery (it is non selective block α1 and α 2)

15. α2 agonist 1.Clonidine : – When administered intravenously or topically (nasal spray) it causes vasoconstriction but when given orally it accumulate in the CNS causing reduction in the sympathetic out flow and hypotension 2.α-methyldopa: – It is a false transmitter, which is a potent agonist to α2 receptors thus causing a powerful inhibition to transmitter release and also have central action,this drug is used to treat hypertension in pregnancy PIH.

16. β1 agonist Only dobutamine which is catecholamine drug is selective agonist to this type of receptors. Β2 selective agonist in high concentration will lose selectivity and stimulate this receptors

17. β2 agonist 1.Salbutamol : – Short acting β2 agonist used to treat asthma and to delay premature labor, the most common side effect is tachycardia and tremor. 2.Terbutaline: – Used to treat asthma and delay the labor 3.Ritodrine: – Used for preterm labor.

18. 4.Clenbuterol: – An anabolic drug used illicitly by athletes to improve performance; – Because in long tem it changes the expression of sarcoplasmic reticulum protein, and thereby increase the rate and force of contraction of the skeletal muscle

19. Β3 agonist Still under clinical trials. If completely developed it will help in weight reduction, by stimulation of lipolysis by β 3.

20. B. Indirect acting sympathomimetic Indirect acting sympathomimetic drugs cause: 1.Norepinephrine release from presynaptic terminals or 2.Inhibit the uptake of norepinephrine. They potentiate the effect of NE,but do not directly affect post-synaptic receptors.

21. 1. Amphetamine It stimulate CNS and also have peripheral action as it displace NE from the vesicles, allowing it to escape in to synaptic cleft It can cause hypertension by increasing the action of NE α receptors by and increase HR and contractility by increasing the action on β receptors. It used clinically for weight reduction as an appetite controller, narcolepsy and ADD with hyperactivity in children. It is also used illicitly by drug abusers to increase concentration and awakens.

22. 2. Tyramine It is not clinically useful drug but it is important because it can be found in fermented food like cheese. It displaces stored catecholamine. Tyramine is particularly important in patient who are taking MAO inhibitors because it escape destruction by MAO in the GIT leading to sever hypertensive crises

23. 3. Cocaine It block the reuptake of NE by blocking Na/K activated ATPase on the cell membrane of adrenergic neuron, consequently NE accumulate in the synaptic space resulting in enhancement of sympathetic activity. TCA also inhibit the reuptake 1 so it increase NA in the synaptic cleft

24. 4. Ephedrine and Pseudoephedrine It displace the NE from stores They are plant alkaloids, they are now made synthetically It is thought that they have direct agonist action on post synaptic adrenergic receptors Ephedrine produces CNS stimulation causing alertness and decrease fatigue, prevent sleep,it also causes bronchodilation and raises systolic and diastolic blood pressure. Note :the clinical use of ephedrine is declining because of the availability of better more potent agents that cause fewer side effects.

25. continue Pseudoephedrine is used clinically as nasal decongestant and has been illegally converted to methamphetamine. Thus, products containing it have certain restriction and must be kept behind sales counter

26. 5. Corticosteroids Inhibit the action of reuptake 2 of NE in the peripheral tissue. This action may the cause of it is therapeutic importance in treating asthma, but it is probably of minor importance.

27. Adrenergic antagonist (sympatholytic)

28. Adrenergic antagonist These group of drug bind to adrenoceptors but do not trigger the usual receptor-mediated response They can be selective or non-selective so they can be classified according to their affinity to the receptors These drugs are either reversibly or irreversibly attached to the receptors, thus preventing the action of endogenous catecholamine

29. A. α blocking agents 1.Phenoxybenzamine: Action: – Irreversibly block both α1 and2 because it make covalent bond with receptors – It causes hypotension by blocking α1 receptors in the blood vessels but blocking α2 may cause more release of NE from the presynaptic neuron which will act on unblocked β receptors in the heart leading to tachycardia so this drug is non suitable for treatment of hypertension

30. Continue Uses: – It is used as pre-surgical treatment of pheochromocytoma to reduce the effect of catecholamine released during manipulation of tissues, it is also used of treatment of this condition if the tumor is inoperable and metastasized – It was used for treatment of peripheral vascular disease but this use is now largely obsolete

31. Adverse effect: – Include nasal stuffiness, – Postural hypotension – Reflex bradycardia mediated by baroreceptors. Thus, it is contraindicated in patient with coronary vessels disease

32. 2. Phenatolamine : Action – Competitively reversibly block both α1 and 2 so their action last only 4 hours after single administration Uses: – It is used for treatment of pheochromocytoma – It was used in the past to treat impotence by injecting the drug intracavernosally to produce vasodilation of penile arteries

33. 3. Prazosin, terazosin, doxazosin and tamsulosin Action: – They selectively block α1 receptors. Uses: – They are useful in treatment of hypertension not like non selective blockers – Tamsulosin in particular is important in treatment of BPH because it reduces the tone of muscle at the bladder neck and facilitate bladder emptying, this drug has minimal effect on blood pressure compared to other drugs of this group because it selectively block Α1a in the bladder smooth muscle.

34. Continue… Precautions: – These drugs can cause first dose hypotension thus need adjustment of the first dose and should be given at bed time – If given as monotherapy for treatment of hypertension the risk of congestive heart failure is increased. Side effect: – Hypotension and male sexual dysfunction – Inhibition of ejaculation and retrograde ejaculation because it causes relaxation of the ejaculatory duct

35. 4. Yohimbine : It is selective competitive α2 receptor antagonist. It is naturally occurring alkaloids extracted from Yohimbine tree. It is CNS and CVS stimulant drug. It was used historically as sexual stimulant.

36. 5. Labetalol and carvedilol They block both α and β receptors Uses: – They cause vasodilation and reduction in the HR and contractility. – It is effective in treatment of hypertension in black and elderly patients. – Labetalol is effective in treatment of hypertension with pregnancy PIH. – Intravenous labetalol is used for treatment of hypertensive emergencies Side effects: – Orthostatic hypotension and dizziness

37. B. β-blocking agents They are divided in to two major groups 1.Non-selective beta antagonist which block both types of beta receptors 2.Selective beta antagonist which block either β1 or β2.

38. 1. Non -selective beta antagonist Propranolol, alprenolol, timolol and nadolol. Uses: – They are used to reduce blood pressure in hypertensive patients by reducing cardiac out- put, inhibition of renin release and reduce sympathetic flow from the CNS – They are also used in treatment of angina, arrhythmias, anxiety, glaucoma (particularly topically applied ones like timolol reduce the secretion of aqueous humor), migraine and hyperthyroidism.

39. Adverse effects – Bronchoconstriction, – Arrhythmias, – Sexual impairment, – Disturbance of metabolism especially glucose (can cause sever hypoglycemia after administration of insulin because it inhibit glucagon release) – Cold extremities because they block the peripheral vasodilation caused by beta 2 adrenoceptors.

40. 2. Selective beta antagonist Acebutolol, atenolol, metoprolol and esmolol They particularly useful in treatment of: – Hypertension in patient with pulmonary disease – Patients with peripheral vascular disease and – Hypertension in diabetic patients

41. Antagonist with partial agonist action Pindolol and acebutolol : They bound to beta 1 and 2 and cause partial stimulation of it but not the full effect and they inhibit the binding of more potent catecholamine. Thus these drugs are named blockers with ISA ( intrinsic sympathomimetic action). It used for treatment of hypertension in patients with moderate bradycardia, because a further decrease in the heart rate is less pronounced with these drugs

42. β2-selective antagonist Butoxamine :beta 2 antagonist with weak alpha agonist action. No clinical use for this drug.

43. Drugs affecting NA release 1. Reserpine: Depletes the stores of NE by inhibiting it is uptake to the vesicles, It was used historically to treat hypertension, Its action is very slow and once started it persists for many days after discontinuation of treatment.

44. 2. Guanthethidine: Inhibit the release of NE and also deplete it and can cause irreversible damage to NA neurons This drug cause transient hypertension at the beginning of treatment then hypotension, Its use for treatment of hypertension is obsolete.

45. References Rang and Dales pharmacology textbook Lippincott's illustrated review pharmacology Pharmacology examination and board review

46. Good luck